Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.62USD
9:02pm BST
Change (% chg)

$-0.04 (-1.09%)
Prev Close
$3.66
Open
$3.68
Day's High
$3.70
Day's Low
$3.59
Volume
28,232
Avg. Vol
46,674
52-wk High
$6.88
52-wk Low
$2.33

Weiner, Barry 

Mr. Barry W. Weiner serves as President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director of the Company. He has served as the Company’s President since 1996, and previously held the position of Executive Vice President. Before his employment with Enzo Biochem, he worked in several managerial and marketing positions at the Colgate Palmolive Company. Mr. Weiner is a member of the New York Biotechnology Association. He received his Bachelor of Arts degree in Economics from New York University and his Master of Business Administration in Finance from Boston University.

Basic Compensation

Total Annual Compensation, USD 542,000
Restricted Stock Award, USD 35,360
Long-Term Incentive Plans, USD --
All Other, USD 669,515
Fiscal Year Total, USD 1,246,880

Options Compensation

  Quantity Market Value
Exercisable 523,342 1,051,290.00
Unexercisable 55,125 249,998.00
Exercised 60,755 352,987.00
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018